Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria)
about
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsRestriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate CancerProgressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
P2860
Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria)
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@ast
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@en
type
label
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@ast
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@en
prefLabel
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@ast
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@en
P2093
P2860
P1476
Combining diffusion and perfus ...... ted imaging abnormality (bria)
@en
P2093
Abdulrahman A Almutairi
Carrie R McDonald
Daniela B Almeida-Freitas
Joshua M Kuperman
Nathan S White
Nikdokht Farid
Santosh Kesari
Scott R VandenBerg
P2860
P2888
P304
P356
10.1007/S11060-014-1583-2
P577
2014-08-19T00:00:00Z
P5875
P6179
1043544631